Company profile
BIOLINERX LTD.
NASDAQ:BLRXBiotechnology: Pharmaceutical Preparations
Drug pipeline (4)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| MOTIXAFORTIDE | phase3 | — | 6 | active |
| MONARSEN | phase2 | — | 1 | no active trials |
| PERPHENAZINE 4-AMINOBUTYRATE | phase2 | — | 4 | no active trials |
| BL-1021 | phase1 | — | 1 | terminated |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (17)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02073019 | phase1 | completed | 2014-08-01 | 2015-07-01 | BioLineRx, Ltd. | A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy Volunteers |
| NCT03246529 | phase3 | active_not_recruiting | 2018-03-23 | 2020-12-22 | BioLineRx, Ltd. | A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM) |
| NCT00480246 | phase1 | completed | 2007-05-01 | — | BioLineRx, Ltd. | A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer |
| NCT00567710 | phase2 | completed | 2008-07-01 | 2009-07-01 | BioLineRx, Ltd. | A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study |
| NCT01121380 | phase1 | terminated | 2011-06-01 | 2011-10-01 | BioLineRx, Ltd. | A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021 |
FDA applications (0)
No records yet.